Alma Osmanovic

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Fingolimod 0.5-mg once-daily is an approved therapy for patients with relapsing-remitting multiple sclerosis (MS). Several pivotal and real-world studies have demonstrated that fingolimod is associated with the development of macular edema (ME). Herein, we present a case of a diabetic MS patient who developed severe bilateral ME during fingolimod treatment.(More)
  • 1